Incidence of the Out- and in Hospital Cardiac Arrest at a Tertiary Hospital in Germany (ProseCPR)

February 1, 2023 updated by: Marc Kriege, MD, Johannes Gutenberg University Mainz

Incidence and Special Informations From Patients of the Out- and in Hospital Cardiac Arrest at a Tertiary Hospital in Germany

Incidence of the background information, incidence and special characteristics of out- and in-hospital cardiac arrest at a tertiary hospital in Germany.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

To evaluate background information for planning a eCPR Program at a tertiary hospital, the investigators planned a prospective study of every out- and in-hospital cardiac arrest.

Study Type

Observational

Enrollment (Anticipated)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Germany
    • Rhineland-Palatinate
      • Mainz, Rhineland-Palatinate, Germany, D55131
        • Recruiting
        • Department of Anesthesiology,Prof. C. Werner, Universitätsmedizin of the JG University
        • Contact:
        • Contact:
          • Eva Wittenmeier, MD
          • Phone Number: 00496131170

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All cardiac arrest patients at a tertiary hospital

Description

Inclusion Criteria:

  • All patients with a cardiac arrest

Exclusion Criteria:

  • not complete fill out evaluation forms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Out-of-hospital cardiac arrest
Patient characteristics; Rescue time intervals; Time to eCPR Decision during high quality CPR;
Other: Time to Decision for eCPR
We evaluate during high quality CPR the time for decision for eCPR
Other Names:
  • Pros eCPR
In-hospital cardiac arrest
Patient characteristics; Emergency team time intervals; Time to eCPR Decision during high quality CPR;
Other: Time to Decision for eCPR
We evaluate during high quality CPR the time for decision for eCPR
Other Names:
  • Pros eCPR

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to eCPR Decision during high quality CPR
Time Frame: < 10 Minutes
After established high quality CPR, we evaluate the time of decision for eCPR
< 10 Minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient characteristics
Time Frame: < 10 Minutes
Age, BMI, comorbidity, contraindications for ECMO
< 10 Minutes
Rescue/Emergency team time intervals
Time Frame: < 60 Minutes
Time to Achievement at the patient; Time for transport
< 60 Minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Johannes Gutenberg University Mainz

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 11, 2023

Primary Completion (ANTICIPATED)

July 11, 2023

Study Completion (ANTICIPATED)

October 31, 2023

Study Registration Dates

First Submitted

January 24, 2023

First Submitted That Met QC Criteria

January 24, 2023

First Posted (ACTUAL)

February 2, 2023

Study Record Updates

Last Update Posted (ACTUAL)

February 3, 2023

Last Update Submitted That Met QC Criteria

February 1, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • JohannesGUC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe